LLY pity that Nordisk is a direct Rival of Eli Lilly, both are my absolute favorite emerging Medical research companies, in a way, it's good for the consumer market, I am investing in both, think Nvidia AMD rivalry. At least for the time being, Eli Lilly is leading ahead.
LLY Tirzepatide should get approved to replace semaglutide in Canada obesity, that goes for several other markets including middle east UAE and Saudi Arabia Eli Lilly will be selling faster than it could produce.